Background
==========

Array-based technologies are revolutionizing genomics, especially the analysis of DNA variation. Array technologies are not without limitations, however, and one major drawback is the poor flexibility of typical array formats. It is cumbersome to create one\'s own tailored arrays by spotting DNA. Commercially available microarrays, on the other hand, either contain a fixed and usually broadly applicable content or are expensive to purchase with customized features. The fixed-content arrays are useful for taking advantage of the high resolution genetic map of the human genome that is based on single nucleotide polymorphisms \[[@B1],[@B1]\], which define DNA blocks (haplotypes) \[[@B1]\]. Since SNPs are the most common type of genetic variation between individuals, it makes sense to utilize them for the localization of disease genes by identifying haplotypes that are associated with phenotypic traits, especially in the case of multifactorial diseases \[[@B1]-[@B5]\]. As a consequence of such a study, however, further analysis is required for improving the resolution of the mapping process or trying to identify the polymorphisms that are actually responsible for the phenotypic variation. Alternatively to the process described above, one can immediately focus on the analysis of particular polymorphisms in candidate genes, if circumstantial evidence indicates their possible relevance to the occurrence of a disease. In either approach the production of a customized microarray is required. Also, experience has demonstrated the need for a careful design of the experimental set-up in order to avoid unacceptable error \[[@B6]\].

Irrespective of the algorithm used for the sequence selection of the probe set, the final functional test of the suitability of an oligonucleotide array for genotyping results from an empirical analysis of the hybridization performance of the oligonucleotide probes. In consequence, it is likely that the initial chip design will be changed by replacing ill-performing oligonucleotides with alternative sequences. For this process, the ability to easily change the chip layout is essential. Light-induced *in situ*synthesis controlled by a micro-mirror device \[[@B7],[@B8]\] combines high synthesis yields of more than 99.5% per condensation \[[@B9]\] -- and therefore good oligonucleotide quality -- with the power of producing oligomer arrays of high density, reproducible characteristics and flexible layout.

In this study, we present the process of establishing an oligonucleotide microarray based on an on-site *in situ*synthesis technology for typing DNA samples in immune regulator genes including cytokines, chemokines and transcription factors. Genetic variants in immune regulator genes have been associated with numerous diseases, including allergies and cancer, with apparently an elevated disease risks in individuals that carry a combination of disease-relevant SNPs. For the array design, we exploited the flexibility of the GeniomOne device \[[@B8]\]. It employs a digital projector to synthesize oligonucleotide array features within channels of a three-dimensional micro-fluidic reaction carrier. The system allows the synthesis of a probe set of up to 64,000 oligonucleotides on a single chip, which subsequently can be hybridized with up to eight samples. For this analysis a microarray that assays 99 relevant SNPs was established by an iterative cycle of probe design and experimental evaluation. Subsequently, the performance of this microarray was investigated in a pilot study. Hay-fever patients aged 40--44 that exhibited high IgE levels against inhalant antigens and an age and sex-matched control group were analyzed.

Results
=======

From a case-control study on hay-fever \[[@B10]\], 19 cases with the most extreme plasma IgE levels against inhalant antigens and 19 age- and sex-matched non-atopic controls were selected for the project. Originally, 141 SNPs in cytokine genes and other immune regulatory factors were selected from published studies and SNP-databases \[[@B11]-[@B13]\]. If possible, SNPs with known or potential functional relevance and allele frequency information were selected. Also, sequence complexity between the probes was meant to be similar, since it is well established that the rate of reassociation depends on sequence complexity \[[@B14]\]. In addition, the initial compilation was based on theoretical calculations of interactions between all oligonucleotide probes and PCR fragments. The program \"SNP CrossChecker\" by Febit GmbH was used to check the cross reactivity between oligoprobes and template sequences reducing the number of PCR-products by 13 to 128. The threshold of maximally possible homology between 23 mere oligoprobe and template sequences was set to 85%. It takes into account that if within the 23 nucleotides of a probe, 20 nucleotides will basepairing with a template, this will produce sufficiently stable complex to produce false positive signals in the genotyping analysis.

Theoretically the probe properties could be assessed basis their sequence similarity and hybridization properties. Experimentally \"bad\" probe has low specificity, sensitivity and uniformity under given reaction conditions (temperature, base composition, salt concentration, hybridization time). Specificity and stability of DNA duplex formation strongly depend on sequence and base composition \[[@B15],[@B16]\]. Also, the target sequence on either side of the SNP position plays an important role since secondary structures may strongly affect the hybridization behavior of a sample \[[@B17]\]. Therefore, it is frequently insufficient to predict hybridization performance merely on the basis of theoretical calculations. Consequently, we analyzed and optimized the experimental parameters of SNP position in the oligonucleotide and the overall length of the probes as well as hybridization temperature and duration. For each SNP, all four possible sequence variations were applied to the chip. One of the probes is designed to be perfectly complementary to a short stretch of the reference sequence (perfect match -- PM) and the other three are identical to the first, except at the interrogation position, where one of the other three bases is substituted (mismatches -- MM). PM/MM scheme enables in addition subtract directly both the background level and cross-hybridization signals providing thus with redundancy required for the reliable microarray analysis. The perfect match probe (PM) is designed complementary to the target sequence and the so-called mismatch probe (MM) is identical with the PM, except the base in the middle of the sequence. Ideally, there is 30-fold difference in the signal intensities of PM vs. MM oligo. In hybridization the oligo signal intensity depends directly of its sequence GC content. Depending on sequence content (high G/C content) the MM oligo can result sufficiently high signal and interfere discrimination between PM and MM signals. In such cases the entire set of 24 oligoprimers, specially designed for detection of one SNP from sense and antisense strands, is underperforming and has to be left out of array design. In addition, we tested positional effects by moving the polymorphic nucleotide from the center to positions +2 and -2 as well as +1 and -1 of the oligonucleotide probes (Fig. [1](#F1){ref-type="fig"}). This shift resulted in differences in signal intensities but did not add to the overall amount of information that could be gathered from an experiment. In consequence, we decided to use only probes that contained the respective SNP in a central position but placed three copies of the same oligosequence at different locations of the microarray.

![**Design a 23 mer oligonucleotide for SNP detection**. In (a) the relevant PCR-product of 166 bp is shown. (b) exhibits the set of oligonucleotides (12 for sense and 12 for antisense strand; at n = 0 the allele is located in the middle of the oligomer, at n = -2 and n = +2 the SNP is shifted by 2 nucleotides to the left and right, respectively.](1471-2164-8-282-1){#F1}

Furthermore, different temperatures for hybridisation (40°C, 45°C, 50°C, and 55°C) and changes in hybridisation time from one to four hours were compared. The time of hybridisation in this experiment had little influence on number of correct and false signals. However, increased hybridisation temperature at 50°C or 55°C reduced cross hybridisation at least 5% and lowered general amount of positive signal to 60% and 40% (respectively). Reduced stringency by decreased hybridisation temperature maximized the overall number and intensity of signals, but this was accompanied with 30% increase of unspecific hybridisation signals.

We also varied probe length, synthesizing on the same chip oligonucleotides of 19, 21, 23, 25 and 27 nucleotides. While longer sequences usually produce higher signal intensities, shorter oligonucleotides permit better discrimination of single base differences due to the more pronounced destabilizing effect of a mismatch. As expected, the signal intensities of both the fully matched (I~1~) and the mismatch probes (I~2~) increased with length while discrimination (I~1~/I~2~) improved the shorter the oligonucleotides were (Fig. [2](#F2){ref-type="fig"}). Measured signal intensity (I~1~) increases clearly with higher nucleotides number in the sequence of oligonucleotide-probe: I~1~(27 bp) \> I~1~(19 bp) (Fig. [3](#F3){ref-type="fig"}). Same effect is obtained for MM (I~2~) oligo-probes as well. Though the discrimination between PM/MM according to the calculated relation of measured intensities (I~1~/I~2~) is higher for shortest set of oligo-probes as 19 bp (5,3\...3,6) and the lowest with 27 bp (1,7\...1,6) ones. Variation of I~1~/I~2~among probes within the same number of nucleotides comes mainly from GC content differences/variations of probe-sequence itself. Why longer MM sequences give higher signal comparing to shorter ones comes mainly from weaker destabilizing effect of noncomplimentary nucleotide on formation of double-stranded complex between probe and target DNA.

![**The dependence of signal intensity on oligonucleotide length**. Hybridization was done at 45°C. *I*~1~*/I*~2~labels the ratio of the signal at the full-match oligonucleotide and the signals at the mismatched oligonucleotides. 27, 25, 23, 21 and 19 indicates the length of oligomers. The SNP was located either at the center of the oligonucleotides (0) or shifted by two bases in either direction (+1, -1).](1471-2164-8-282-2){#F2}

![**Differences in the performance of oligonucleotides**. Set 1 to 6 label the oligonucleotides designed for detecting a SNP. Each column indicates the signal intensity at the oligomers that represent (left to right) the A, G, C or T variant of a sequence. Sets 1 to 3 are the data produced on replicate microarray positions that represent one strand, while sets 4 to 6 indicate the signal intensities produced by the complementary DNA strand. Panel (1) shows the result obtained for a heterozygous sample, panel (2) a homozygous sample. Panel (3) exhibits data obtained with an oligonucleotide that was predicted *in silico*to perform well but failed in the experiment. In panel (4) a result of an oligomer with a high degree of cross-hybridization is presented.](1471-2164-8-282-3){#F3}

Tests at different hybridization temperatures (40--55°C) produced the overall best results for the majority of SNPs with 23-mer probes and 3 to 4 hours of hybridization at 45°C. Finally, the selected set of oligoprobes, as well as the hybridization conditions, were tested in addition with 4 genomic DNA samples of control individuals. These control experiments had 5-fold redundancy. Concordance of analyzed genotypes were compared individually.

For selecting the best performing oligoprobes in the initial optimization experiments one test-DNA with good quality was used. All hybridization reactions from chip design step were repeated 3 times. During the optimization process, we identified several oligonucleotide probes that did not perform irrespective of the chosen hybridization conditions (e.g., Fig. [2](#F2){ref-type="fig"}). Apparently, the previously described selection basis of cross-reactivity could be even more stringent e.g. we should allow less base pairing. Following experimental tests revealed additional oligoprobe sets falling out from final chip design because of the same reason. Herewith, basis on experimental results, the threshold for software based oligo probe selection could be set on 80% allowing less base pairing (and less false signals due to nonspecific oligo hybridization) than 85%. In total, 29 out of the 128 SNPs (22%) could not be analyzed adequately. The respective oligomer probes that had been defined as good by the *in silico*selection process were empirically found to be ill-performing in real hybridizations. Either the absolute signal intensity was too low to permit a statistically solid analysis or the discriminative effect was insufficient. The ratio between PM and MM oligo signal intensities is supposed to be at least 1/3 (Fig. [3](#F3){ref-type="fig"}). The high number of failing oligonucleotides illustrates the need for a careful experimental validation of *in silico*designed microarrays.

Using the optimized microarray, we performed genotyping analyses at 99 SNPs in 68 genes that have a putative functional significance for the occurrence of hay-fever. From a case-control study on hay-fever \[[@B10]\], 19 cases with the most extreme plasma IgE levels against inhalant antigens and 19 age- and sex-matched non-atopic controls were selected. Informed consent of the participants was given in writing and the local ethics committee approved the study. PCR-amplifications of the relevant DNA-regions were performed either individually or in pools of 5 or 10 samples. While all pentaplex reactions yielded a product for each individual band, two decaplex amplifications failed to produce 1 out of the expected 10 amplicons (Fig. [4](#F4){ref-type="fig"}). The 99 products were pooled prior to labelling and hybridized concomitantly (Fig. [5](#F5){ref-type="fig"}). For each sample, analysis was repeated up to four times. The observed allele frequencies are presented in Table [1](#T1){ref-type="table"}. To assess the accuracy of the genotyping, ten PCR-products of heterozygote calls obtained from the microarray analyses were subjected to gel-based DNA sequencing for confirmation. In all cases, the results were in full agreement.

###### 

Relative allele frequences of SNPs genotyped in 19 hay fever patients with extreme IgE phenotype and 19 non-atopic controls.

  **SNP Nr.**   **SNP name**   **SNP identifier**   **Allele 1**   **Relative frequence of allele 1 in case sample**   **Relative frequence of allele 1 in control sample**
  ------------- -------------- -------------------- -------------- --------------------------------------------------- ------------------------------------------------------
  1             IL-2_1         rs2069772            T              0.58                                                0.83
  2             IL-2_2         rs2069763            G              0.67                                                0.61
  3             IL-10_4        rs1800894            G              1.00                                                1.00
  4             IL-10_5        rs1800871            C              0.77                                                0.83
  5             IL-10_6        rs1800872            C              0.77                                                0.83
  6             TNFA_7         rs11565              C              0.85                                                0.92
  7             TNFA_8         rs673                A              0.03                                                0.03
  8             TNFA_9         rs1800629            A              0.16                                                0.05
  9             TNFA_10        rs361525             A              0.11                                                0.03
  10            IL4_11         rs2243246            T              0.95                                                0.86
  11            IL4_12         rs2243250            C              1.00                                                1.00
  12            IL4_13         rs34185442           C              1.00                                                1.00
  13            IL4_14         rs2970874            C              1.00                                                0.97
  14            IL6_16         rs1800797            G              0.63                                                0.60
  15            IL6_16         rs1800796            G              1.00                                                1.00
  16            IL6_17         rs1800795            G              0.63                                                0.47
  17            IL4R_18        rs1801275            A              0.87                                                0.68
  18            IL4R_19        rs1805011            C              0.05                                                0.13
  19            IL4R_20        rs8832               G              0.75                                                0.62
  20            IL4R_21        rs1805015            T              1.00                                                0.89
  21            IL4R_22        rs1805010            A              0.70                                                0.56
  22            IL12p40_23     rs3124               C              1.00                                                1.00
  23            STAT6_24       rs167769             A              0.32                                                0.20
  24            STAT6_25       rs324015             G              0.72                                                0.82
  25            STAT6_26       rs703817             G              0.50                                                0.38
  26\*          STAT6_27       rs4559               A              0.27                                                0.25
  27            IFNG_28        rs2234685            A              1.00                                                1.00
  28            IFNG_29        rs1861493            T              0.69                                                0.69
  29            IFNG_30        rs2234687            C              1.00                                                1.00
  30\*          IFNG_31        rs2430561            T              0.50                                                0.38
  31            IFNGR2_34      rs1802585            C              1.00                                                1.00
  32            IFNGR2_35      rs1059293            T              0.39                                                0.50
  33            IFNGR2_36      rs9808753            A              0.86                                                0.94
  34            IRF1_37        rs839                G              0.74                                                0.89
  35\*          IRF1_38        rs9282762            A              0.42                                                0.60
  36\*          IRF2_40        rs1131553            G              0.32                                                0.50
  37            IL8_41         rs1175               A              0.41                                                0.47
  38            IL8_42         rs2227307            G              0.42                                                0.50
  39            IL13_43        rs20541              G              0.89                                                0.79
  40            IL13_44        rs1800925            C              0.88                                                0.82
  41\*          IL18_47        rs1946518            G              0.63                                                0.67
  42\*          IL18_48        rs1946519            C              0.87                                                0.71
  43\*          IL1B_49        rs16944              T              0.16                                                0.15
  44            IL1B_50        rs1143627            C              0.36                                                0.38
  45            IL1B_51        rs1799916            T              1.00                                                1.00
  46            IL1A_52        rs17561              G              0.64                                                0.74
  47            IL1A_53        rs1800587            T              0.36                                                0.31
  48            IL9_56         rs1799962            A              1.00                                                1.00
  49            TNFR1_60       rs1800692            C              0.63                                                0.53
  50            TNFR1_61       rs1800693            A              0.53                                                0.72
  51\*          TNFRSF6_62     rs2234768            T              0.00                                                1.00
  52            LTA_65         rs1800683            A              1.00                                                1.00
  53            LTA_66         rs1041981            A              0.29                                                0.19
  54            LTA_67         rs909253             G              0.25                                                0.19
  55            IL1RN_68       rs2234676            G              0.86                                                0.74
  56            IL1RN_69       rs419598             T              0.87                                                0.88
  57            CTLA4_70       rs2384137            G              0.11                                                0.06
  58            NFKBIA_72      rs1800439            G              0.53                                                0.56
  59            IL8RB_77       rs2230054            T              0.06                                                0.17
  60            ICAM1_78       rs1799969            A              1.00                                                0.97
  61\*          ICAM1_79       rs5498               G              0.61                                                0.64
  62            IL3_81         rs40401              G              0.95                                                0.94
  63            IL3_82         rs31480              G              0.84                                                0.82
  64            MCP1_87        rs4611511            A              0.89                                                0.92
  65            MCP1_88        rs34020694           A              0.87                                                0.87
  66            RANTES_89      rs2107538            G              0.88                                                0.91
  67            RANTES_90      rs2280788            C              0.95                                                0.95
  68            CCR5_91        rs1799863            A              0.03                                                0.00
  69            CCR2_94        rs1799865            T              0.50                                                0.56
  70            C5_95          rs17611              G              0.66                                                0.50
  71            C5_96          rs17612              C              0.11                                                0.06
  72            P2X7_97        rs3751143            C              0.06                                                0.03
  73            IL7R_106       rs1494555            G              0.34                                                0.35
  74            PRF1_107       rs885822             T              0.83                                                0.94
  75            TLR2_108       rs1804965            G              1.00                                                1.00
  76            TCL1B_109      rs1064017            G              0.44                                                0.56
  77            CCR5_110       rs1800452            G              1.00                                                1.00
  78            IL11_111       rs1126757            A              0.38                                                0.44
  79            IL11_112       rs2298885            G              0.61                                                0.85
  80            IL8RA_117      rs2234671            G              0.40                                                0.44
  81\*          IL1L1_118      rs1800930            A              0.78                                                0.83
  82\*          CD36_119       rs1334512            G              0.96                                                0.85
  83            VDR_121        rs1544410            G              0.31                                                0.44
  84\*          VDR_122        rs7975232            T              0.73                                                0.54
  85            IL5RA_123      rs2290610            A              0.83                                                0.61
  86            IL5R_124       rs2069812            C              0.79                                                0.78
  87            IL5R_125       rs2069818            C              1.00                                                1.00
  88            CX3CR1_126     rs3732379            G              0.68                                                0.67
  89            CX3CR1_127     rs3732378            C              0.78                                                0.74
  90\*          TNFRSF1B_128   rs1061622            T              0.88                                                0.65
  91            TNFRSF1B_129   rs1061624            A              0.31                                                0.47
  92            TNFRSF1B_130   rs3397               T              0.88                                                0.79
  93\*          TNFRSF1A_131   rs887477             G              0.54                                                0.35
  94            TNFRSF1A_132   rs4149570            G              0.76                                                0.53
  95            IL4R_135       rs1805016            T              1.00                                                1.00
  96            IL6_137        rs20069860           A              0.97                                                1.00
  97\*          IL9_138        rs20069885           C              1.00                                                0.96
  98\*          NKFB_139       rs1020759            C              1.00                                                1.00
  99            GATA3_141      rs57013              A              0.72                                                0.58

\* The SNP detection reproducibility \<80%

![**Gel-electrophoretic separation of the products of multiplex-PCR**. Two decaplex amplifications are shown in comparison to the respective individual reactions. In both cases presented here, one product was not amplified in the multiplex reaction while the reaction worked fine in the individual amplification.](1471-2164-8-282-4){#F4}

![**Image of a simultaneous hybridization of 99 PCR-products to an *in situ*synthesized oligonucleotide microarray**. Usually, the features were scrambled across the array. For illustrative purposes, they were placed next to each other in this particular experiment.](1471-2164-8-282-5){#F5}

Hybridization experiments for all studied 38 individuals were repeated twice.

16% of SNPs presented only one allele in the 38 studied samples. For 14 samples (7 cases and 7 controls) the call rate for all variants was above 90%. And in one case it was below 80% due to the low quality of this particular DNA sample. For 17 SNPs the amplification step basically failed due to low quality of clinical genomic DNA samples. After exclusion of these particular 17 SNPs (indicated with an asterisk in Tab. [1](#T1){ref-type="table"}) that performed poorly in hybridizations the average concordance was 93%. From the variants with high quality data, five SNPs in the genes *IL2*(rs2069772), *TCL1B*(rs1064017), *IL11*(rs2298885), *IL5RA*(rs2290610) and *TNFRSF1A*(rs4149570) had p-values smaller than 0.05 for the association of carrying the mutant allele with the high IgE phenotype. The homozygous genotype A for the IL5 receptor alpha (*IL5RA*Ile129 Val) was associated with a 6.8-fold risk (95% confidence interval, 1.6--29.1) of a high IgE phenotype.

Discussion
==========

An oligonucleotide microarray was produced using GeniomOne device to facilitate the screening of single nucleotide polymorphisms in several genes that are associated with hay-fever as a pilot project. Based on an *in silico*design, the selected set of oligonucleotides was optimized by a subsequent experimental analysis. While the *in silico*process eliminated 9% of the initially 141 SNPs that had been picked purely on the basis of a potential association with the occurrence of hay-fever, the subsequent experimental validation eliminated another 20% of these oligomers, more than twice as many. This result illustrates the importance of experimental validation of the microarray designs. Even in analyses that are based on a continuous detection of the hybridization and dissociation process (dynamic allele-specific hybridization) \[[@B18]\] the selection is critical, although an analysis of the association and dissociation curves of the duplexes permit a more discriminative and accurate SNP detection.

The reasons for the failing probes could be manifold \[[@B19]\]. Although only short fragments were hybridized, secondary structures formed either within one sample molecule or between different targets could cause inefficient binding to the array-bound probe molecules. Also, it is well known that dangling ends of the target molecules may have a profound effect on the hybridization \[[@B20]\]. Documentation of the effectiveness of the genotyping ability of particular sets of oligonucleotide probes is essential for a study of high accuracy. Use of flexible *in situ*synthesized oligonucleotide microarrays to such ends appears to be an efficient and attractive method for fast and cost-efficient pre-screening of candidate SNPs for an eventual high-throughput genotyping.

GeniomOne allows synthesizing 8 × 8.000 probes per array overnight and test them right after in hybridization experiments. In this way many combinations can be tested in parallel without additional cost, which allows selecting an optimal set of oligoprobes for the following experiments. This is a big advantage of GeniomOne technology.

In the analysis of the 38 DNA samples of hay-fever cases and controls, we were able to identify at least five polymorphisms in immune regulator genes that contribute to the extreme IgE phenotype and deserve further testing. For 22% of the selected SNPs, only one genotype was seen in 38 individuals. For several variants, allele-frequency differences between cases and controls exceeded 10%. These include non-synonymous variants in the IL5 receptor alpha (*IL5RA*Ile129 Val) and *TCL1B*(Gly93Arg), promoter polymorphisms in *IL2*(-330 T/G) and *TNFRSF1A*(-609 G/T), and a polymorphism in the 3\' UTR of *IL11*. *IL5RA*is a crucial factor in IL5 signalling and a contributor to the genetics of atopy in mice \[[@B21]\]. The extreme phenotype design of the study performed here may be an efficient alternative for the identification of disease-relevant sequence variants.

Conclusion
==========

Based on a platform that permits flexible *in situ*oligonucleotide synthesis, a set of optimally performing probes could be defined by a selection approach that combined computational and experimental aspects. The final design achieved by this process permitted an effective discrimination of both homo- and heterozygote polymorphisms in hay-fever patients. Allele-frequencies of more than 10% could be identified.

Methods
=======

Microarray synthesis
--------------------

All analysis steps, (i) *in situ*synthesis of the oligonucleotide microarray, (ii) hybridization of the labeled PCR-product mixture and (iii) detection of the signal intensities were performed with the GeniomOne device of febit biotech (Heidelberg, Germany) according to the manufacturer\'s instructions. The reaction carrier (DNA-processor) represents a microstructured disposable system that consists of four or eight individual arrays, respectively, which can be used individually or in any combination \[[@B8]\]. Controlled by a mask-free, light-controlled process, oligonucleotide probes were synthesized *in situ*in 3\' to 5\' direction \[[@B9]\]. For each selected SNP, 24 oligonucleotide probes were synthesized, 12 for either DNA strand (Fig. [1](#F1){ref-type="fig"}), all designed to exhibit similar hybridization characteristics. The arrays used in this study consisted of 7,448 distinct oligonucleotides (594 perfect match probes and 6,534 mismatch probes, plus 320 copies of a control oligonucleotide). A complete list can be obtained from the authors.

PCR-amplification
-----------------

For each SNP, PCR-primers were designed for the amplification of the relevant DNA-fragment using the *Primer3*program \[[@B22]\]. All primers have a Tm value of 60°C. The oligonucleotides were obtained from Thermo Hybaid (Ulm, Germany). Their sequences are presented in the Table [2](#T2){ref-type="table"}. The length of the PCR-products varies between 100 bp and 270 bp.

###### 

Primer sequences used for PCR-amplification of the SNP-regions.

  **No.**   **SNP Name**   **SNP ID**   **Forward Primer (5\'-3\')**   **Reverse Primer (5\'-3\')**
  --------- -------------- ------------ ------------------------------ --------------------------------
  1         IL-2_1         rs2069772    CCATTCTGAAACAGGAAACCA          CTTTAAGGGGGTGGGGATAC
  2         IL-2_2         rs2069763    TGCAACTCCTGTCTTGCATT           ACTTACATTAATTCCATTCAAAATCA
  3         IL-10_4        rs1800894    TCCAGCCACAGAAGCTTACA           GTGCTCACCATGACCCCTAC
  4         IL-10_5        rs1800871    TCCAGCCACAGAAGCTTACA           GTGCTCACCATGACCCCTAC
  5         IL-10_6        rs1800872    TCCAGCCACAGAAGCTTACA           GTGCTCACCATGACCCCTAC
  6         TNFA_7         rs11565      ACCACAGCAATGGGTAGGAG           CATGCCCCTCAAAACCTAT
  7         TNFA_8         rs673        ACCACAGCAATGGGTAGGAG           CGTCCCCTGTATTCCATACCT
  8         TNFA_9         rs1800629    GCCCCTCCCAGTTCTAGTTC           GCATCAAGGATACCCCTCA
  9         TNFA_10        rs361525     GCCCCTCCCAGTTCTAGTTC           GCATCAAGGATACCCCTCA
  10        IL4_11         rs2243246    GCCCCTCCCAGTTCTAGTTC           GCATCAAGGATACCCCTCA
  11        IL4_12         rs2243250    AGTGAGTGGTGGGGTCCTTA           AATGCCCACTTTTTGAATGG
  12        IL4_13         rs34185442   ACCCAAACTAGGCCTCACCT           GGTGGCATCTTGGAAACTGT
  13        IL4_14         rs2970874    GGAAGAGAGGTGCTGATTGG           CGATTTGCAGTGACAATGTG
  14        IL6_16         rs1800797    GGAAGAGAGGTGCTGATTGG           CGATTTGCAGTGACAATGTG
  15        IL6_16         rs1800796    TGGCAAAAAGGAGTCACACA           CCCAAGCCTGGGATTATGAAG
  16        IL6_17         rs1800795    TGGCAAAAAGGAGTCACACA           CCCAAGCCTGGGATTATGAAG
  17        IL4R_18        rs1801275    GCTAGCCTCAATGACGACCT           TCATGGGAAAATCCCACATT
  18        IL4R_19        rs1805011    GAAACCTGGGAGCAGATCCTC          GGCCTTGTAACCAGCCTCTC
  19        IL4R_20        rs8832       AAAGGGAGCTTCTGTGCATC           TCTCCGAGCTGGTCCAG
  20        IL4R_21        rs1805015    TTCCTTAGGTTGATGCTGGAG          GGTTCCATGCATACGAGGAG
  21        IL4R_22        rs1805010    ACCTGACTTGCACAGAGACG           AGGGCATGTGGGTTCTACT
  22        IL12p40_23     rs3124       GCCTACAGGTGACCAGCCTA           AGCCCACGGTCCAGTGTAT
  23        STAT6_24       rs167769     CACAACGGAATAGACCCAAAA          ATGGCAACTTGAGAGCTGGA
  24        STAT6_25       rs324015     GCACTGACTGGAAGGGAAGT           CCCTAACCTGTGCTCTTACCC
  25        STAT6_26       rs703817     GTCTCAGCCCTAGGGGAATG           CTCCACCTGGCTAACAGGAA
  26        STAT6_27       rs4559       CAAAAGTACAAGGGCTGA             CCCAAATTTGTGTTGTCACG
  27        IFNG_28        rs2234685    GGAAGTAGGTGAGGAAGAAGCG         TGGAGCAAAGAAGGTCATCA
  28        IFNG_29        rs1861493    GGAAGTAGGTGAGGAAGAAGCG         TGGAGCAAAGAAGGTCATCA
  29        IFNG_30        rs2234687    TCCCATGGGTTGTGTGTTTA           GGGTCACCTGACACATTCAA
  30        IFNG_31        rs2430561    TTCAGACATTCACAATTGATTTTATTC    CCCCAATGGTACAGGTTTCT
  31        IFNGR2_34      rs1802585    CCCAACTCAGCCCATCTTAG           ATCTCTTCCAGGGAGCCAGT
  32        IFNGR2_35      rs1059293    GGGCTGAGCAGTCAGAA              CATTTTAAGCCAGCACACCA
  33        IFNGR2_36      rs9808753    CAGAGCAGGTCCTGAGTTGGGAGC       GTTTCCCACGGGTTTGATAA
  34        IRF1_37        rs839        GGACTGTTCCAAAGCCAGTG           CAGAAATGTGGCAAGATCCA
  35        IRF1_38        rs9282762    TTGCAAACTAAGAAAGCACACAA        ATGGGTGACACCTGGAAGTT
  36        IRF2_40        rs1131553    CTCCCAAAGTGCTGGGATTA           CTGTTGTAAGGCACCGGATT
  37        IL8_41         rs1175       CTTCACCATCATGATAGCATCTGT       GGAGTATGACGAAAGTTTTCTTTG
  38        IL8_42         rs2227307    TGCTTTGGTAACAAACATCCTTT        GGTAACCGTCCTTCTCAATAGG
  39        IL13_43        rs20541      CTTCCGTGAGGACTGAATGAGAC        CTGCAAATAATGATGCTTTCGAAGTTTCAG
  40        IL13_44        rs1800925    TGACATCAACACCCAACAGG           GCAGAATGAGTGCTGCTGTGGAG
  41        IL18_47        rs1946518    GGTCAGTCTTTGCTATCATTCCAG       AGCCACACGGATACCATCAT
  42        IL18_48        rs1946519    GGTCAGTCTTTGCTATCATTCCAG       AGCCACACGGATACCATCAT
  43        IL1B_49        rs16944      AGCCTGAACCCTGCATACC            CAATAGCCCATCCCTGTCTGT
  44        IL1B_50        rs1143627    TCTCAGCCTCCTACTTCTGCTT         CAGAGAGACTCCCTTAGCACCT
  45        IL1B_51        rs1799916    TCTCAGCCTCCTACTTCTGCTT         CAGAGAGACTCCCTTAGCACCT
  46        IL1A_52        rs17561      CCCCCTCCAGAACTATTTTCC          ACTTTGATTGAGGGCGTCAT
  47        IL1A_53        rs1800587    TAGGCTGGCCACAGGAATTA           AGCCAGAACCAGTGGCTAAG
  48        IL9_56         rs1799962    CCTTCGTTAGAACACCCATGA          AGACAGGGATTCTGGTGTGA
  49        TNFR1_60       rs1800692    TCCCCCTCCTGTATTCTGTG           GTGCACACGGTGTTCTGTTT
  50        TNFR1_61       rs1800693    CCTGGAGTGCACGAAGTTGT           ATAGATGGATGGGTGGGATG
  51        TNFRSF6_62     rs2234768    CATCCTCCTTATCCCACTTCTTT        CACCCTGTGTTTTGCATCTA
  52        LTA_65         rs1800683    CACTGCCGCTTCCTCTATAA           GGTAGTCCAAAGCACGAAGC
  53        LTA_66         rs1041981    CCCCCTCAACTCTGTTCTCC           GGGAGGTCAGGTGGATGTTT
  54        LTA_67         rs909253     GGGTTTGGTTTTGGTTTCCT           CAGAGAAACCCCAAGGTGAG
  55        IL1RN_68       rs2234676    GCCCATCTCCTCATGCTG             GCTGCTGCCCATAAAGTAG
  56        IL1RN_69       rs419598     TCCTTTTCAGAATCTGGGATGT         CGTGATGCCCAGATACATTG
  57        CTLA4_70       rs2384137    AACACCGCTCCCATAAAGC            CCTCCTCCATCTTCATGCTC
  58        NFKBIA_72      rs1800439    CCTTGTTTTCAGCTGCCCTA           TCGTCCCCTACAAAAAGTTCA
  59        IL8RB_77       rs2230054    ACATTCCAAGCCTCATGTCC           TACCAGGGCAGGCTTTCTA
  60        ICAM1_78       rs1799969    CTTGAGGGCACCTACCTCTG           AGGATACAACAGGCGGTGAG
  61        ICAM1_79       rs5498       CTTGAGGGCACCTACCTCTG           AGGATACAACAGGCGGTGAG
  62        IL3_81         rs40401      GAGCAGTTAACCCAGCTTGTC          CACCTTGCTGCTGCACATA
  63        IL3_82         rs31480      GAGCAGTTAACCCAGCTTGTC          CACCTTGCTGCTGCACATA
  64        MCP1_87        rs4611511    AAAGCTGCCTCCTCAGAGTG           CACAGGGAAGGTGAAGGGTA
  65        MCP1_88        rs34020694   AGAGAAAACCCGAAGCATGA           TCTTCCTAGGCCATCTCACC
  66        RANTES_89      rs2107538    ATCCAGAGGACCCTCCTCAA           GGAGTGGCAGTTAGGACAGG
  67        RANTES_90      rs2280788    TTCTTTTCCGTTTTGTGCAAT          CGTGCTGTCTTGATCCTCTG
  68        CCR5_91        rs1799863    CTGCCTCCGCTCTACTCACT           GCCAGGTTGAGCAGGTAG
  69        CCR2_94        rs1799865    AGAGGCATAGGGCAGTGAGA           GGTCCAGTTGACTGGGTGCTT
  70        C5_95          rs17611      TGCAGTTTGCCCTACCTGAT           TGCTACCATTTAAGTCCTGGGTA
  71        C5_96          rs17612      TTTTAGCTACAAGCCCAGCA           AATGAAGCATTCACAACACGA
  72        P2X7_97        rs3751143    TTCCTGGACAACCAGAGGAG           ACCAGCTTCCTGAACAGCTC
  73        IL7R_106       rs1494555    CACTATAGTTAAACCTGAGGCTCC       TCCTGGCGGTAAGCTACATC
  74        PRF1_107       rs885822     CCCAGGTCAACATAGGCATCC          CGAACAGCAGGTCGTTAAT
  75        TLR2_108       rs1804965    ATTCTTCTGGAGCCCATTGA           GGACTTTATCGCAGCTCTCA
  76        TCL1B_109      rs1064017    ACAGTGCACTTGTGGCAG             CTGGCCATGGTCTGCTATTT
  77        CCR5_110       rs1800452    TAGTCATCTTGGGGCTGGTC           TGTAGGGAGCCCAGAAGAGA
  78        IL11_111       rs1126757    GGGACCACAACCTGGATTC            ATCAGAGAACACCCGACCAG
  79        IL11_112       rs2298885    GGCTGTGTTCACCATAGCAA           ATCCCAAGCAAGCCTCTCTC
  80        IL8RA_117      rs2234671    CATCTTTGCTGTCGTCCTCA           CCAGAATCTCAGTGGCATCC
  81        IL1L1_118      rs1800930    GATGGTGCTACTGCTGTGGA           GGGCTCAGGGTAACACTG
  82        CD36_119       rs1334512    CTGGCAACAAACCACACACT           TCCTACACTGCAGTCC
  83        VDR_121        rs1544410    CCTCACTGCCCTTAGCTCTG           CAGGAATGTTGAGCCCAGTT
  84        VDR_122        rs7975232    CTGCCGTTGAGTGTCTGTGT           ACGTCTGCAGTGTGTTGGAC
  85        IL5RA_123      rs2290610    CCATGGCAATGTTTTGTCCT           CAGGTGCAGTGAAGGGAAAC
  86        IL5R_124       rs2069812    CTTGCTTTTTCCTGCTGCTC           AGTCCAGGAATGGAGGCTCT
  87        IL5R_125       rs2069818    TGTGGAGAAGAAAGACGGAGA          CAAAATCTTTGGCTGCAACAAACCA
  88        CX3CR1_126     rs3732379    GGTGGTCATCGTGTTTTTCC           AGGCAACAATGGCTAATGC
  89        CX3CR1_127     rs3732378    GGTGGTCATCGTGTTTTTCC           AGGCAACAATGGCTAATGC
  90        TNFRSF1B_128   rs1061622    CTCCTGACCAAGCCTCCTC            GTCACTGGCTGGGGTAAGTG
  91        TNFRSF1B_129   rs1061624    TCCTCTAGTGCCCTCCACAG           CACAGAGAGTCAGGGACTTGC
  92        TNFRSF1B_130   rs3397       TCCTCTAGTGCCCTCCACAG           CACAGAGAGTCAGGGACTTGC
  93        TNFRSF1A_131   rs887477     CAGCACAACTGGTCAGAACC           CCTCCTCCCAGTTCAACAAG
  94        TNFRSF1A_132   rs4149570    TACAGGAACCCCAGGAGACA           TGGGTTCCAATTCAGAATGCTT
  95        IL4R_135       rs1805016    GTGTCATGGCCAGGAGGAT            AGACTGGCCTCCAGTGGAAC
  96        IL6_137        rs20069860   TCCCTCCACTGCAAAGGATT           CTGCAGCCACTGGTTCTGT
  97        IL9_138        rs20069885   ACTTTCATCC CCACAGT             TTGCCTCTCATCCCTCTCAT
  98        NKFB_139       rs1020759    TGCTTCCCTCTTGTGTTTCA           GGGGATGACCTTTAAGTGGA
  99        GATA3_141      rs57013      TCCATCCATTGCACTGAGTC           CCAGAGCAGCTGGTTTAAGTG

Genomic DNA from lymphocytes was extracted using the QiaAmp Blood kit according to the manufacturer\'s instructions (Qiagen, Hilden, Germany). PCR-amplifications of individual loci were carried out in a Mastercycler gradient thermocycler (Eppendorf-Netheler-Hinz, Hamburg, Germany) in 25 μl of 1× Thermoprime polymerase puffer (AB Gene, Epson, UK), 200 μmol/l of each deoxynucleotide triphosphate (Qiagen), 1.5 mmol/L MgCl~2~(AB Gene), 0.25 units Thermoprime DNA polymerase (AB Gene), 1.0 to 2.5 μmol/l of both forward and reverse primer, and 20 ng DNA. The initial annealing occurred at 94°C for 2 min, followed by 30 cycles of 94°C for 40 sec, 57°C for 40 sec and 72°C for 30 sec. Subsequently, a final extension step was performed at 72°C for 1 min.

Multiplex-PCR was performed in a total volume of 25 μl solution containing 80 ng human genomic DNA, 1.2 μmol/l of each primer, 1 mmol/l deoxynucleotide triphosphates (dNTPs), 5 mmol/l MgCl~2~and 2 units of Thermoprime Plus DNA polymerase (AB Gene). All primer pairs had been checked *in silico*for possible primer dimers using the program \"Primer Premier 5\" (Premier Biosoft International, Palo Alto, USA).

DNA amplification for individuals, studied in present work, was done as described in single PCR cycling reactions. All PCR-products were checked by electrophoresis on 2% agarose gels.

Sample processing
-----------------

About 200 ng of each PCR-product were pooled and purified with the QIAquick PCR purification kit (Qiagen) according to the manufacturer\'s instructions. Biotin 3\'-end labeling was performed as described \[[@B8]\]. In brief, the eluate resulting from the purification step was dried in a vacuum concentrator and the pellet was dissolved in 5 μl of water. Labeling was performed in a total volume of 10 μl with 2.5 U terminal transferase (Roche, Mannheim, Germany), 0.1 mmol/L Biotin-N^6^-ddATP (PerkinElmer, Rodgau, Germany), 2.5 nmol/l CoCl~2~and 1× reaction buffer (Roche). After 1 h incubation at 37°C, the enzyme was inactivated at 99°C for 15 min and the mixture cooled on ice.

The final sample hybridization cocktail was made of 10 μl of this labeling reaction, 4 μl herring sperm DNA (0.1 mg/mL with 0.5 mg/ml BSA), 9 μl 2 × 2-\[N-morpholino\]ethanesulfonic (MES) acid buffer \[54.8 mmol/l MES (free acid monohydrate), 147.7 mmol/l MES sodium salt, 1.8 mol/l NaCl, 40 mmol/l Na~2~EDTA, 0.02% (v/v) Tween20\] and 6 μl water. As an internal hybridization control, 1 μl of a mixture of biotin-(50 nmol/l) and Cy5-labeled (250 nmol/l) control oligonucleotides (GCAGTGCTGCCATAACCATGAGTGA, CGCAAACTATTAACTGGCGAACTAC, GAACTGGATCTCAACAGCGGTAAGA, AAGATCAGTTGGGTGCACGAGTGGG, CGCAACAATTAATAGACTGGATGG, GCAGTGCTGCCAAAACCATGAGTGA), supplied by febit biotech, were added. The total volume of the hybridization mixture was 30 μl, which was stored frozen until use at -20°C.

Hybridization and detection
---------------------------

The DNA-fragments of all SNPs of one individual person were analyzed simultaneously in a single hybridization. The biotin-labeled PCR-products in the hybridization mixture were denatured at 99°C for 5 min and quickly cooled on ice for 2 min. The probe arrays were incubated with 1 × MES solution (containing 1% BSA) at room temperature for 15 min. Then the hybridization mixture was loaded to the array. Hybridization was performed at 45°C for 4 h. Subsequently, the used sample was recovered and the array was washed with 0.5 × SSPE buffer (diluted from 6 × SSPE stock-solution consisting of 0.9 mol/l NaCl, 60 mmol/l NaH~2~PO~4~(pH 7.4) and 6 mmol/l Na~2~EDTA) at 45°C. Staining was performed with 4 ml of 2.5 μg/ml streptavidin R-phycoerythrin conjugate (Molecular Probes, Cologne, Germany) in 6 × SSPE at room temperature for 10 minutes. All these steps were carried out automatically by the GeniomOne instrument.

Data analysis
-------------

Image analysis was done automatically with the GeniomOne system-embedded CCD imaging system. All steps such as configuration of detection parameters, acquisition of array image, detection of feature position, calculation of signal intensity and data export to a database were performed automatically. The pattern recognition rules are digitally encoded in the analysis software, simplifying and shortening the result reading. Raw data were further processed with the integrated analysis software with the default settings.

Statistical analysis of epidemiological data
--------------------------------------------

The analysis was performed with SAS software PHREG version 9 (SAS Institute, Cary, USA). Relative risk of the elevated IgE phenotype associated with genetic variants was estimated by odds ratios (OR) and associated 95 percent confidence limits using the procedure for conditional logistic regression. The gene variants were computed as simultaneous limits of the parameters of a multinomial distribution according to Nieters et al. \[[@B23]\].
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